← All studies
Methods & AIProtocol published · review underway

Hybrid type II methods

Statistical methods, outcome structures and research designs in hybrid type II effectiveness–implementation studies

Role
Senior investigator · led by Dr. Marc Parsons, CTN+ Postdoctoral Fellow
Design
Scoping review (JBI guidance, PRISMA-ScR)
Stage
Protocol published · review underway
The problem

Hybrid type II studies give roughly equal weight to whether an intervention works and whether the strategy used to implement it works. That dual emphasis creates statistical problems: two primary endpoints raise multiple-testing questions, most of these studies are cluster randomized, and designs such as stepped-wedge and sequential multiple-assignment trials produce outcomes that change over time, dose or strategy intensity. Methodological solutions exist, but how often they are applied, and how authors justify their choices, is unclear.

What we are investigating

Describe the statistical and design approaches used in published hybrid type II studies that state an equivalent emphasis on effectiveness and implementation endpoints.

Examine how trajectory outcomes are determined and how levels of the independent variable, such as time, dose or strategy intensity, are justified.

Examine how authors justify the type II label and operationalize the bivariate outcome structure.

Where the study stands

The protocol was published in F1000Research on 13 August 2026 (version 1, awaiting peer review) and registered on the Open Science Framework. Searches and screening are underway.

How we are doing it

The review follows JBI scoping-review guidance and will be reported with PRISMA-ScR. Embase, Medline, Scopus and Web of Science are searched for hybrid type II studies and for methodological guidance on their design or analysis, with no limit on publication type. Two reviewers extract data independently; statistical methods are categorized alongside study characteristics such as the implementation strategy, and methodological guidance is summarized narratively.

What the work will produce
  • A map of the statistical methods, outcome structures and designs in use, against the methods available
  • A narrative summary of existing methodological guidance for hybrid type II designs
  • Priorities for methodological development, to inform the planning and reporting of future hybrid type II studies
How partners contribute

An author group across McGill University, the CTN+ Methods Think Tank, McMaster University, the University of Utah and The Ohio State University, with the lab's medical librarian.

Study publications
Related background

The TIDieR and AACTT secondary analysis is listed because it examines how implementation strategies, the other half of a hybrid design, are specified and reported.

Enquire about this review

Collaborations and trainee projects on hybrid effectiveness–implementation designs and their analysis.

Email the study team